ANDREW ROBITAILLE: Open Payments
NPI 1316414162 · BOXFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 34 payments from 8 companies in 2025. Trend: 2023 $23 · 2024 $29 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 17 | $313 |
| ABBVIE INC. | 9 | $242 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: VYEPTI, QULIPTA, UBRELVY, BOTOX, RELISTOR, SPRAVATO, AUSTEDO XR, MOVANTIK.
Industry payments across MA — which companies pay providers there.
